Cargando…
Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study
OBJECTIVE: The occurrence of partial remission (honeymoon phase) in type 1 diabetes (T1D) has been associated with a reduced risk of chronic microvascular complications of diabetes. We have published case reports showing that a combination therapy with the DPP-4 inhibitor sitagliptin plus vitamin D3...
Autores principales: | Pinheiro, Marcelo Maia, Pinheiro, Felipe Moura Maia, de Arruda, Marcelo Müller, Beato, Geane Moron, Verde, Graciele Alves Corrêa Lima, Bianchini, Georgiana, Casalenuovo, Pedro Rosário Moraes, Argolo, Aline Aparecida Agostini, de Souza, Lucilene Telles, Pessoa, Flávia Gomes, Hirose, Thiago Santos, Senra, Eduardo Filgueiras, Ricordi, Camillo, Fabbri, Andrea, Infante, Marco, Diniz, Susana Nogueira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665061/ https://www.ncbi.nlm.nih.gov/pubmed/37249465 http://dx.doi.org/10.20945/2359-3997000000652 |
Ejemplares similares
-
Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i)
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2021) -
Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2016) -
Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2023) -
Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012) -
Acute kidney injury based on KDIGO (Kidney Disease Improving Global
Outcomes) criteria in patients with elevated baseline serum creatinine undergoing
cardiac surgery
por: Machado, Maurício Nassau, et al.
Publicado: (2014)